Everyone’s got access to some kind of data these days—public records, rent comps, sales history, cap rates. But here’s the thing nobody wants to say out loud: none of that matters if you can’t read between the lines. Medical real estate is loaded with nuance. Maybe the property’s got great fundamentals, but the main tenant is a struggling physician group. Maybe there’s hospital affiliation—but the hospital is planning a new MOB two blocks away. Maybe the rents look  high—but they’re inflated by tenant improvement packages that wiped out yield. You don’t get that insight from a spreadsheet. This is where market intelligence comes in. It’s not about flooding you with stats. It’s about drawing a clean line between the noise and the signal—so you can move faster, negotiate better, and avoid mistakes that don’t show up until after the close. And while AI and automation are part of the process, they’re not the whole picture. You still need people who actually know what they’re looking at—and who’ve been around long enough to spot the red flags and hidden upside. That’s what we do. No fluff. No filler. Just real-world market intelligence designed for the way decisions actually get made. 📞 Let’s talk through your deal or strategy Book a 15-minute call 🗞️ Prefer updates in your inbox? Sign up for the newsletter

Things aren’t slowing down yet. Here’s what deserves your attention in the upcoming week: 🔧 CT Hospital Fallout:  In Connecticut, bankrupt Prospect Medical Holdings just secured an additional $30 million in emergency financing  to keep operating three hospitals. That follows a larger loan earlier in the year. No sale auction has closed yet, putting pressure on valuation terms, landlord credit risk, and potential distressed ownership scenarios  . 🌿 Boerne, TX Breakthrough:  One Seven Business Park—a 40,000 sq ft medical office development near San Antonio—began interior build-outs in late July for its first shell space. Completion is slated for September, signaling steady suburban demand in fast-growing Hill Country markets  . 🏥 Kansas City Hospital Opening:  AdventHealth’s Lenexa City Center—the first hospital in Lenexa, Kansas—opened mid‑July. Phase one includes a 96-bed facility and 56,000 sq ft of contiguous medical office. It marks $247 million in development and permanent on-campus MOB pipeline for future expansion  . 🧬 Charlotte Innovation District Ramps:  The Pearl medical innovation district in Charlotte continues progress. Featuring mixed-use labs, retail, and a new Wake Forest med school campus, the district is expected to deliver a new wave of life science and outpatient office activity in Q3–Q4  . Why it matters: The Connecticut funding deal highlights how bankrupt operators can complicate valuations  and sale-leaseback terms. Boerne’s medical park launch is a textbook example of emerging suburban outpatient demand  where population growth meets aging demographics. The Lenexa opening signals hospital campus plus MOB planning , which becomes the blueprint for capital-intensive outpatient strategy. Charlotte’s Pearl reinforces the rising role of innovation districts  in creating mixed-use healthcare campuses—and potential new tenants, investors, and value-add plays. 📅 Want to review deals or comp alignment for any of these developments? 👉 Book a 15‑minute call 📰 Prefer to receive market intelligence you can actually use? 👉 Subscribe to the monthly newsletter

This week delivered some hard signals in medical real estate—suburban medical office action, portfolio-sized campus plays, and senior housing financing volume that matters. 🩺 Northern Virginia portfolio deal Remedy Medical Properties and Kayne Anderson Real Estate quietly closed on eight medical office buildings totaling about 800,000 sq ft  across Northern Virginia. These include a six-story, 120K sq ft building leased to Children’s National Health System, near Inova Fairfax Hospital. It’s a major market move, expanding institutional presence in a metro outpatient ecosystem. The price wasn’t disclosed, but tax records suggest valuation in the $300M‑plus range  . 🏥 Morristown, NJ single‑asset trade A boutique 58,440 sq ft building in Morristown Medical Corridor sold for $13.2 million . Fully occupied and one mile from Morristown Medical Center, the property includes tenants like radiology, pain consultants, and medical groups. The cap rate works out to attract top-tier investor demand for stable suburban ground-up investments  . 🔁 $100M milestone in Phoenix Kidder Mathews’ healthcare real estate team hit a major benchmark: nearly $100 million in sales  and 100 transaction closings  regionally through mid‑2025. It’s a solid sign that CRE activity—especially MOB leasing and small trades—is accelerating across secondary and tertiary Western markets  . 💵 Senior financing surges Berkadia’s Seniors Housing & Healthcare platform closed over $1.13 billion  in new loans during the first half of 2025. That covers 64 senior housing assets in sectors from assisted living to skilled nursing, including HUD and GSE financing solutions  . That level of lending reflects both strong demand and underwriting confidence in stable operations. Why these moves matter Institutional appetite remains strong  in high-quality MOB portfolios with credit anchors. Suburban single-asset trades  continue to attract local and regional capital when tenancy and location align. Financing momentum  in the senior housing space confirms capital is flowing again—especially for operationally resilient assets. Data volume matters —when teams hit $100M in activity, it means deal flow and execution are scaling. 📅 Want to walk through your local comps or test the underwriting on a deal? 👉 Book a 15-minute call 📰 Want sharp, monthly market insight with zero filler? 👉 Subscribe here

The headlines say it’s a boom. MOB demand is up. Behavioral health is expanding. New projects breaking ground from Texas to the Carolinas. But not all noise is signal. We’ve seen three big deals recently that looked promising on paper—but the deeper we dug, the less solid the foundation became. One was tied to a health system in a reimbursement squeeze. Another was leased to a startup multispecialty group with aggressive growth plans but little cash on hand. The third? Overbuilt submarket with a high vacancy rate they tried to gloss over with “strong tenant interest.” This is why market intelligence matters. It helps you cut through the spin and get real about risk, timing, and return. Because in a noisy market, your edge isn’t speed—it’s clarity. 📅 Need a second set of eyes on something? Book a call 📰 Stay sharp with our monthly intel: Join the list

A lot of medical real estate deals are moving on momentum right now. Operators “feel good” about a market. Investors like the area. Brokers say it’s hot. But when the spreadsheets hit the table, the story changes. We’re seeing assets priced off of comps that are two years old. Rent escalations that don’t line up with regional reimbursement. Lease terms that assume zero downtime in a shaky submarket. That’s where market intelligence cuts through the noise. It brings you back to what’s actually performing—not what everyone wants to believe. A clean PDF and a handshake don’t hold up in front of lenders, equity partners, or your own balance sheet. The data has to work. 📅 Want someone to test the assumptions before you pull the trigger? Book a quick call

Everyone likes to talk about cap rates. That’s usually the first number thrown around in a deal conversation. But in medical real estate, the real risk often hides somewhere else. Take a recent deal we reviewed—new construction, great tenant, long lease, 6.15 cap. Looked clean on the surface. But the tenant’s business model was razor-thin, with regional exposure to outdated Medicaid reimbursement schedules. The lease might be strong on paper, but the operator wasn’t. That’s the kind of thing you miss without real market intelligence. Knowing the market rent isn’t enough. You need to understand tenant risk, reimbursement trends, sale-leaseback history, and the health of the service line. You need to ask who else looked at the deal and walked away. This is where most deals live or die—and it’s the difference between transactional underwriting and true diligence. Market intelligence gives you the full picture before you commit. 📅 Want to run a deal by someone who knows what cracks to look for? Book a quick call 📰 Get no-fluff intel each month: Sign up here

Every market has its hot deals. And every market has the ones that look good—until someone does the math. We’ve been reviewing several transactions this month where broker materials projected strong returns, but the fundamentals told another story. In one case, the pro forma assumed rent increases well above market averages… with no justification. In another, a value-add play ignored deferred maintenance costs entirely. That doesn’t mean the brokers are wrong—it means they’re focused on a different part of the process. Their job is to bring energy and interest to a deal. Ours is to bring clarity. Market intelligence isn’t just a lender checkbox. It’s a grounding force in a market that runs hot. It tests assumptions, benchmarks risk, and tells you whether the asset holds up under pressure—because when things get tight, wishful underwriting won’t save you. Whether you’re buying, building, or refinancing, having a market intelligence partner who’s seen the cycle before can make all the difference. 📅 Want a second set of eyes on a deal? Book a quick call 📰 Get intel like this monthly: Join the newsletter

Ask five people what a good medical real estate deal looks like, and you’ll get five numbers. But price is rarely the full story—and if you’re not looking beneath the surface, you’re missing the parts that actually matter. We’re seeing more investors bid aggressively on on-campus MOBs or surgical centers with zero attention to how that income was built. Is the tenant paying market rent or subsidized by a health system? Is the lease arms-length or tied to a physician group’s practice sale? What happens if that anchor vacates? None of that shows up in the closing price. But it all shows up in the valuation. Good evaluations go beyond cap rate compression and lease term. They ask: Is this income stable? Replaceable? Scalable?  Because that’s what lenders, partners, and long-term investors really want to know. So while everyone’s chasing deals, we’re chasing clarity. And when you’re ready to get a real read on value—not just a number on paper—that’s when we should talk. 📅 Book a 15-minute call 📰 Subscribe to the newsletter

A few key moments this week are worth noting—they won’t make headlines but will shape the medical CRE market in the months ahead. First, Charlotte Healthcare Summit (July 17) —though technically last week, its ripple effects roll right into this one. The regional forum brought together hospital systems, developers, MOB investors, and lenders for a deep dive into outpatient demand and lifecycle capital strategy   . Expect continued conversations around absorption rates, lease structures, and site selection—particularly in secondary markets. Also, keep an eye on Cushman & Wakefield’s Q2 senior living investor survey , due later this week. Its May results showed over 89% nationwide occupancy and cap rate compression expectations—but Q2 data might highlight whether that momentum is holding or cooling  . On the federal level, the BOMA Medical Real Estate Conference recap  dropped last month in Denver, but the materials and insights are still circulating—and will drive deal strategy this week. Look for follow-up webcasts or proprietary content on CRE tooling for outpatient expansion, legal frameworks, and adaptive reuse strategies  . Here’s what you should be watching: Any mention of lease-term shifts or reimbursement changes  for outpatient and senior housing assets—especially from attendees or sponsors. Data releases on tax credit logistics  or municipal support for new healthcare infrastructure—these can shift underwriting overnight. Uptake of AI and automation by operators , particularly in senior living communities—a trend we’ve flagged, and one that’s gaining traction in public sector and legal definitions. If you’re modeling occupancy, underwriting debt, or advising on outpatient projects, this week presents an opportunity to recalibrate… quietly but meaningfully. 📅 Want to talk through capital strategy, drawings for Q3 pipeline, or fresh POV on senior housing absorption? 👉 Book a 15-minute chat 📰 Interested in a clean, monthly briefing with no fluff? 👉 Subscribe here

This week didn’t have a headline, but it had traction—you just needed to look closely. Chicago suburb deal blooms MedProperties Realty Advisors quietly closed on the 41,540 sq ft Millennium Medical Center in Chicago Ridge. Built by local physicians in 2018, it’s anchored by a US Oncology affiliate and leased long‑term. It’s not flashy, but it’s exactly the kind of physician‑aligned, built‑to‑use asset that continues to defy broader office trends  . Midwest outpatient taste Davis Healthcare picked up a 28,000 sq ft MOB in Maplewood, MN for $9.85 million—leased 86 % to M Health Fairview on a 10‑year lease. That’s $352/sf in a metro with steady demographics but less runway than coastal peers  . Senior living capital starts flowing Cambridge Realty Capital closed $19.3 million in HUD loans this week—primarily in Missouri and Texas—to refinance and shore up senior housing. It’s not investor fireworks, but it shows the sector’s resilience and confidence in long‑term financing  . Turnkey memory care hits bid deadline Hilco put a 120,000 sq ft assisted‑living/memory care asset in Cape Coral out for bids this week, fully leased and cash‑flow positive—current yield around $2 million on a 135‑bed community. It’s the kind of off‑market, income‑producing play investors chase quietly  . Why it matters These aren’t splashy headlines—but they’re signal-rich: Physician and operator‑aligned assets are still winning in suburban MOBs. Subtle but steady investor activity in senior housing shows lending and liquidity remain available. Off‑market senior assets with stable income are still moving—even in quiet weeks. 📅 Want to dive into similar assets or explore cap rate trends in MOBs and senior housing? 👉 Book a 15‑minute strategy call 📰 Want this on your inbox monthly—no fluff, just intel? 👉 Subscribe to the newsletter

For all the noise about private equity rollups and REIT portfolios, physician-owned medical buildings continue to quietly outperform. They may not make headlines, but they make money—and they often fly under the radar during institutional bidding frenzies. The key advantage? Alignment. When the operator owns the dirt, there’s typically less turnover, stronger reinvestment, and better community ties. And in smaller metro markets, physician groups that own their real estate often operate more efficiently than their corporate-backed counterparts. It’s also a defensive play. In times of rate uncertainty, long-term owner-users are less exposed to refi pressure or leaseback renegotiations. If anything, they’re buying more—especially when they can add an ASC or imaging suite next door. From a valuation standpoint, these deals demand a different lens. It’s not just about cap rates and lease comps. You have to look at physician stability, generational succession planning, and what happens if the group ever sells. A good appraisal doesn’t just reflect income—it reflects reality. Whether you’re an investor, broker, or developer, don’t write off these owner-user assets. They may be the most stable thing in your pipeline. 📅 Want a second set of eyes on a physician-owned asset? Book a 15-minute call 📰 Want insights like this in your inbox each month? Sign up for the newsletter

It’s not flashy. It’s not fast. But senior living is getting stronger every month—and July’s numbers are the latest proof. Brookdale just posted its June occupancy report, and it’s telling. Same-community occupancy now sits at 82.8%, with systemwide rates trending up for the 17th straight quarter. That’s not just recovery. That’s momentum. Investors are noticing. A new CBRE survey found most senior living buyers expect rent growth and cap rate compression over the next 12 months. And while big institutional money is still cautious, regional players are getting aggressive—especially in states with strong Medicaid waivers or growing 75+ populations. But the real shift is happening under the radar. Infill projects with flexible care licenses, mid-market communities with fewer amenities but better staffing ratios, and even cohousing pilots are all gaining traction. Cohousing in particular—long a staple in Denmark—is showing early promise here in the US. It’s less about flash, more about community, and it’s something we’ll be keeping an eye on. On the ground, we’re seeing deals move fastest when appraisals take a hard look at tenant credit, real capex, and market-rate labor assumptions. Because in senior living, value isn’t just the building—it’s the operator’s ability to keep it full, staffed, and compliant. If you’re modeling a new build, looking to value a stabilized asset, or need help pressure-testing assumptions, now’s the time to take a closer look. 📅 Want to talk it through? Book a quick call 📰 Want these updates in your inbox each month? Sign up here